Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1/2 1

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Breast 7Gastrointestinal 5Thoracic 3CNS 3Sarcoma 1Plasma cell 1Head & Neck 1Genitourinary 1Classical hematology 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Neoplasms 1Motor Activity 1Liver Neoplasms 1Liver Diseases 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Carcinoma, Pancreatic Ductal 1Adenocarcinoma 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Lead × Gastrointestinal × Clear all
NCT03292289 2026-03-17

QUALIPRO

Centre Oscar Lambret

Phase NA Completed
65 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05931068 2024-08-05

PRO-NRG

Academisch Ziekenhuis Maastricht

Recruiting
20 enrolled
Gastrointestinal

Liver Diseases, Liver Neoplasms, Motor Activity, Neoplasms

NCT06472063 2024-06-24

SNAC

San Luigi Gonzaga Hospital

Recruiting
684 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02800330 2018-08-02

REGORA

Erasmus Medical Center

Phase 4 Completed
31 enrolled
GastrointestinalSarcoma

Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT01808638 2016-03-11

Atu027-I-02

Silence Therapeutics GmbH

Phase 1/2 Completed
29 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡